Human Genome Epidemiology Literature Finder
|
Records 1 - 20 (of 20 Records) |
| Query Trace: Fibrosis and CALR[original query] |
|---|
| Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis. Annals of hematology 2016 Jul . Pei Yu-Qing, Wu Yue, Wang Fei, Cui W |
| Bone marrow microvessel density and plasma angiogenic factors in myeloproliferative neoplasms: clinicopathological and molecular correlations. Annals of hematology 2016 Dec . Lekovic Danijela, Gotic Mirjana, Skoda Radek, Beleslin-Cokic Bojana, Milic Natasa, Mitrovic-Ajtic Olivera, Nienhold Ronny, Sefer Dijana, Suboticki Tijana, Buac Marijana, Markovic Dragana, Diklic Milos, Cokic Vladan |
| Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms. Blood 2016 12 129 (6): 680-692. Rumi Elisa, Cazzola Mar |
| Re: Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis. Annals of hematology 2016 Sep . Kourie Hampig Raphael, Ameye Lieveke, Paesmans Marianne, Bron Dominiq |
| Genetic Risk Assessment in Myeloproliferative Neoplasms. Mayo Clinic proceedings 2017 8 92 (8): 1283-1290. Tefferi Ayalew, Vannucchi Alessandro Mar |
| [The clinical characteristics, gene mutations and prognosis of chronic neutrophilic leukemia]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2017 Jan 38 (1): 28-32. Cui Y J, Jiang Q, Liu J Q, Li B, Xu Z F, Qin T J, Zhang Y, Cai W Y, Zhang H L, Fang L W, Pan L J, Hu N B, Qu S Q, Xiao Z |
| The prognostic relevance of serum lactate dehydrogenase and mild bone marrow reticulin fibrosis in essential thrombocythemia. American journal of hematology 2017 Feb . Mudireddy Mythri, Barraco Daniela, Hanson Curtis A, Pardanani Animesh, Gangat Naseema, Tefferi Ayal |
| The clinical and prognostic relevance of driver mutations in 203 Taiwanese patients with primary myelofibrosis. Journal of clinical pathology 2017 Dec . Kuo Ming-Chung, Lin Tung-Huei, Sun Chien-Feng, Lin Tung-Liang, Wu Jin-Hou, Wang Po-Nan, Huang Ying-Jung, Chang Hung, Huang Ting-Yu, Shih Lee-Yu |
| Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria. Oncotarget 2017 12 8 (60): 101735-101744. Rumi Elisa, Boveri Emanuela, Bellini Marta, Pietra Daniela, Ferretti Virginia V, Sant'Antonio Emanuela, Cavalloni Chiara, Casetti Ilaria C, Roncoroni Elisa, Ciboddo Michele, Benvenuti Pietro, Landini Benedetta, Fugazza Elena, Troletti Daniela, Astori Cesare, Cazzola Mario, |
| MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 Dec JCO2017764886. Guglielmelli Paola, Lasho Terra L, Rotunno Giada, Mudireddy Mythri, Mannarelli Carmela, Nicolosi Maura, Pacilli Annalisa, Pardanani Animesh, Rumi Elisa, Rosti Vittorio, Hanson Curtis A, Mannelli Francesco, Ketterling Rhett P, Gangat Naseema, Rambaldi Alessandro, Passamonti Francesco, Barosi Giovanni, Barbui Tiziano, Cazzola Mario, Vannucchi Alessandro M, Tefferi Ayal |
| Essential thrombocythaemia with mutation in MPL: clinicopathological correlation and comparison with JAK2V617F-mutated and CALR-mutated genotypes. Journal of clinical pathology 2018 6 71 (11): 975-980. Alvarez-Larran Alberto, Martínez Daniel, Arenillas Leonor, Rubio Ariadna, Arellano-Rodrigo Eduardo, Hernández Boluda Juan Carlos, Papaleo Natalia, Caballero Gonzalo, Martínez Clara, Ferrer-Marín Francisca, Mata María Isabel, Pérez-Encinas Manuel, Durán María Antonia, Alonso José María, Carreño-Tarragona Gonzalo, Alonso Juan Manuel, Noya Soledad, Magro Elena, Pérez Raúl, López-Guerra Mónica, Pastor-Galán Irene, Cervantes Francisco, Besses Carlos, Colomo Luis, Rozman Mar |
| Pyrosequencing-based quantitative measurement of CALR mutation allele burdens and their clinical implications in patients with myeloproliferative neoplasms. Clinica chimica acta; international journal of clinical chemistry 2018 5 483 183-191. Oh Yejin, Song Ik-Chan, Kim Jimyung, Kwon Gye Cheol, Koo Sun Hoe, Kim Seon You |
| GATA1 Expression in BCR/ABL1-negative Myeloproliferative Neoplasms. Annals of laboratory medicine 2018 Jul 38 (4): 296-305. Yang Naery, Park Sholhui, Cho Min Sun, Lee Miae, Hong Ki Sook, Mun Yeung Chul, Seong Chu Myong, Huh Hee Jin, Huh Jungw |
| Mutation profile in Indian primary myelofibrosis patients and its clinical implications. South Asian journal of cancer 2019 9 8 (3): 186-188. Patil Vinod R, Chandrakala S, Mantri Shruti, Patil Rajesh, Wasekar Nilesh, Jijina Far |
| [The genetic characteristics of BCR-ABL-negative myeloproliferative neoplasms]. Zhonghua nei ke za zhi 2019 12 59 (1): 35-39. Lyu X D, Li Y W, Guo Z, Xin Y P, Hu J Y, Fan R H, Song Y |
| [Pathological characteristics of megakaryocytes in myeloproliferative neoplasms and their correlation with driver gene mutations]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2020 11 41 (10): 798-805. Shi Z X, Zhang P H, Li B, Fang L H, Xu Z F, Qin T J, Liu J Q, Hu N B, Pan L J, Qu S Q, Liu D, Xiao Z |
| [Clinical impact of gene mutations on myeloproliferative neoplasms in Japan]. [Rinsho ketsueki] The Japanese journal of clinical hematology 2021 9 62 (8): 1060-1069. Morishita So |
| Triple-Negative Essential Thrombocythemia: Clinical-Pathological and Molecular Features. A Single-Center Cohort Study. Frontiers in oncology 2021 4 11 637116. Cattaneo Daniele, Croci Giorgio Alberto, Bucelli Cristina, Tabano Silvia, Cannone Marta Giulia, Gaudioso Gabriella, Barbanti Maria Chiara, Barbullushi Kordelia, Bianchi Paola, Fermo Elisa, Fabris Sonia, Baldini Luca, Gianelli Umberto, Iurlo Alessand |
| Clinicopathologic spectrum of myeloid neoplasms with concurrent myeloproliferative neoplasm driver mutations and SRSF2 mutations. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2022 Jun . Tashakori Mehrnoosh, Khoury Joseph D, Routbort Mark J, Patel Keyur P, Wang Sa A, Ok Chi Young, El-Hussein Siba, Kanagal-Shamanna Rashmi, Luthra Rajyalakshmi, Hu Shimin, Lin Pei, Pemmaraju Naveen, Bose Prithviraj, Verstovsek Srdan, Bueso-Ramos Carlos E, Medeiros L Jeffrey, Loghavi San |
| Essential thrombocythaemia progression to the fibrotic phase is associated with a decrease in JAK2 and PDL1 levels. Annals of hematology 2022 Oct . Lewandowski Krzysztof, Kandu?a Zuzanna, Gniot Micha?, Paczkowska Edyta, Nawrocka Paulina Maria, Wojtaszewska Marzena, Janowski Micha?, Mariak Magdalena, Handschuh Luiza, Kozlowski Pio |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: